Skip Nav Destination
Abstract 2276: Sorafenib/Refametinib potently inhibits Wnt/β-catenin in vitro and patient-derived xenograft models of human hepatocellular carcinoma
Cancer Res (2016) 76 (14_Supplement): 2276.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Seyed Alireza Javadinia
- Soodabeh Shahidsales
- Azar Fanipakdel
- Mona Joudi‐Mashhad
- Mehrane Mehramiz
- Sahar Talebian
- Mona Maftouh
- Ramin Mardani
- Seyed Mahdi Hassanian
- Majid Khazaei
- Gordon A. Ferns
- Amir Avan
Journal of Cellular Biochemistry (2019) 120 (5): 6833.
- Nithya Krishnamurthy
- Razelle Kurzrock
Cancer Treatment Reviews (2018) 62: 50.
